Pepaxto is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Oncopeptides, Ab. The primary component is Melphalan Flufenamide.
| Product ID | 73657-020_779bf257-f198-4c8e-8ddf-87d3c14d8c77 | 
| NDC | 73657-020 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Pepaxto | 
| Generic Name | Melphalan Flufenamide | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2021-02-26 | 
| Marketing Category | NDA / | 
| Application Number | NDA214383 | 
| Labeler Name | Oncopeptides, AB | 
| Substance Name | MELPHALAN FLUFENAMIDE | 
| Active Ingredient Strength | 20 mg/50mL | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2021-02-26 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() PEPAXTO  79275014  not registered Live/Pending  | 
        Oncopeptides AB  2019-11-05  |